In this piece, we discuss the Billionaire Portfolio: 7 Cheap Stocks Top Billionaires Are Accumulating.
The equity market continues to face a challenging backdrop amid rising geopolitical tensions, Reuters reported on March 27, 2026.
With the Middle East conflict now four weeks old, investors continue to pull their money out of the market as concerns surrounding inflation, growth, and consumer demand mount further. This week marked a fifth straight week of declines for Wall Street’s three main indexes.
According to Hargreaves Lansdown’s Matt Britzman, investor sentiment is not driven by price action alone. In fact, the lack of visible progress toward easing the conflict in the Middle East is weighing on investor confidence. Polar Capital’s Dan Boston expanded on that, noting that rising food and transportation costs are strengthening the case for higher inflation and hampering consumer sentiment.
On the other hand, Ocean Park Asset Management’s James St. Aubin cited the same factors, arguing that investor excitement around AI is fading. In the last quarter of 2025, the Nasdaq rose to record highs amid robust momentum in tech plays.
Thus, investor focus has shifted from growth themes like AI to macro risks tied to surging oil prices and rising bond yields. To make matters worse, market participants are now seeing a roughly 60% chance of a U.S. rate hike in 2026.
With this background in mind, let’s turn to our list of billionaire portfolio: 7 cheap stocks top billionaires are accumulating.
Photo by Joshua Hoehne on Unsplash
Methodology
For this article, we scanned the top billionaire holdings, looking for stocks trading at or below 15x forward earnings. We then ranked the list by the number of billionaires bullish on each stock as of Q4 2025, in ascending order. For billionaire sentiment, we relied on Insider Monkey’s billionaire database, which tracks over 100 billionaires as of Q4 2025.
Note: All data was extracted as of March 27, 2026.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 498.7% since May 2014, beating its benchmark by 303 percentage points (see more details here).
7. The Cigna Group (NYSE:CI)
The Cigna Group (NYSE:CI) is among our picks in the list titled billionaire portfolio: 7 cheap stocks top billionaires are accumulating.
As of March 27, 2026, The Cigna Group (NYSE:CI) enjoys the confidence of roughly 90% of covering analysts who maintain bullish ratings on the stock. Based on the analyst consensus, the stock boasts an approximately 30% upside potential.
Similar optimism echoed at Bernstein, where analysts expect the stock’s valuation multiple to expand. Analyst confidence stems from drivers such as the PBM reform bill, the FTC settlement, The Cigna Group (NYSE:CI)’s previously announced PBM model changes, and its guidance tied to those changes.
With this investment thesis, Bernstein boosted its 2027-2030 EPS estimates, upgrading The Cigna Group (NYSE:CI) from “Market Perform” to “Outperform.” As of March 12, 2026, the firm maintains a $358 price target. For the current year, it kept its EPS estimates unchanged.
Recently, The Cigna Group (NYSE:CI) announced a leadership change, under which CEO David Cordani will retire, and Brian Evanko will succeed him. While the succession was inevitable, the timing of the move was criticized by Barclays analysts earlier this month, who cited the company’s early stage in its multi-year PBM transformation.
Around the same time, Piper Sandler’s analysts remained in favor of the PBM model changes, seeing less risky business dynamics following the change. Analysts further added that the company’s rebate-free pharmacy benefits model aligns with the 2025 Consolidated Appropriations Act and the FTC settlement. The firm cut its price target on The Cigna Group (NYSE:CI) from $374 to $370 and reiterated an “Overweight” rating.
The Cigna Group (NYSE:CI) operates as a global health services provider that offers pharmacy benefit management, specialty pharmacy, care delivery, and medical insurance solutions through its Evernorth Health Services and Cigna Healthcare segments worldwide.
